Concomitant use of steroids or phototherapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study

被引：0
|
作者：
Querfeld, Christiane [1 ]
Turini, Marco [2 ]
Gor, Deval [3 ]
Angello, James T. [2 ]
Pashos, Chris [3 ]
Kim, Ellen J. [4 ]
机构：
[1] City Hope Comprehens Canc Ctr, Div Dermatol, Duarte, CA USA
[2] Helsinn Healthcare SA, Lugano, Switzerland
[3] Genesis Res LLC, Hoboken, NJ USA
[4] Univ Penn, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 156卷
关键词：
Chlormethine gel; registry; observational study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tre-P-01
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 40 条
  • [21] Treatment duration as a function of clinician-level patient volume: mechlorethamine treatment for mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)
    Querfeld, Christiane
    Pacheco, Theresa
    Haverkos, Bradley
    Binder, Gary
    Angello, James
    Poligone, Brian
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S8 - S8
  • [22] A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort Study
    Querfeld, Christiane
    Pacheco, Theresa
    Haverkos, Bradley
    Binder, Gary
    Angello, James
    Poligone, Brian
    FRONTIERS IN MEDICINE, 2021, 8
  • [23] The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma (vol 22, pg 407, 2021)
    Kim, Ellen J.
    Guitart, Joan
    Querfeld, Christiane
    Girardi, Michael
    Musiek, Amy
    Akilov, Oleg E.
    Angello, James T.
    Bailey, William L.
    Geskin, Larisa J.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 425 - 425
  • [24] Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings (vol 39, pg 3979,2022)
    Wehkamp, Ulrike
    Ardigo, Marco
    Papadavid, Evangelia
    Querfeld, Christiane
    Nikbakht, Neda
    ADVANCES IN THERAPY, 2023, 40 (03) : 1299 - 1300
  • [25] HEALTHCARE RESOURCE USE IN MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA: RESULTS FROM A UK-BASED CLINICIAN QUESTIONNAIRE
    Scarisbrick, J.
    Schmidt, F.
    Turini, M. M.
    D'agostino, P.
    Summers, D.
    van Hest, N.
    Evans, J.
    VALUE IN HEALTH, 2020, 23 : S693 - S694
  • [26] Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
    Liner, Kendall
    Brown, Celeste
    McGirt, Laura Y.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 241 - 254
  • [27] Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma
    Mitteldorf, C.
    de Masson, A.
    Beylot-Barry, M.
    Wobster, M.
    Zomas, A.
    Stache, V.
    Assaf, C.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S77 - S78
  • [28] Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study
    Kim, Ellen J.
    Geskin, Larisa
    Guitart, Joan
    Querfeld, Christiane
    Girardi, Michael
    Musiek, Amy
    Mink, David R.
    Williams, Michael J.
    Angello, James T.
    Bailey, William L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (03) : 928 - 930
  • [29] Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sezary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data
    Remak, Edit
    Hawkins, Neil
    Jones, Trefor
    Otley, Marissa
    Twigger, Robert
    Prince, Miles
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S18 - S18
  • [30] PATIENTS' EXPERIENCES WITH MYCOSIS FUNGOIDES/SEZARY SYNDROME - CUTANEOUS T-CELL LYMPHOMA (MF/SS-CTCL): EVIDENCE FROM QUALITATIVE RESEARCH OF A PATIENT REPORTED OUTCOME (PRO) MEASURE DEVELOPED ON AN ONLINE RESEARCH PLATFORM
    Towner, A.
    Raja, P.
    Braverman, J.
    Harrington, M.
    Simacek, K.
    Nagao, M.
    Sepassi, M.
    VALUE IN HEALTH, 2015, 18 (03) : A25 - A25
1234